[Mechanisms of innate and acquired resistance to Trypanosoma cruzicruzi].
Defense mechanisms against the parasite Trypanosoma cruzi, the etiologic agent for dilated myocardiopathy and Chagas disease are reviewed, in vitro studies and experimental models are described and commented. Applying new techniques derived from Molecular Biology for the study of Chagas disease, both at experimental and clinical level could be rewarding and maybe useful to design effective treatment for this irreversible heart disease in humans.
Monteón
V M
VM
Lab. de Inmunología del Instituto Nacional de Cardiología Ignacio Chávez, México, D.F.
Reyes López
P A
PA
D000818:Animals; D000913:Antibodies, Protozoan / Q000276:immunology*; D007111:Immunity, Cellular / Q000276:immunology; D007113:Immunity, Innate / Q000276:immunology; D010587:Phagocytosis / Q000276:immunology*; D014349:Trypanosoma cruzi / Q000276:immunology*
D000913:Antibodies, Protozoan
Mecanismos de resistencia innata y adquirida al Tripanosoma cruzi.